Jenney Adam, Chibo Doris, Batty Mitch, Druce Julian, Melvin Robert, Stewardson Andrew, Dennison Amanda, Symes Sally, Kinsella Paul, Tran Thomas, Mackenzie Charlene, Johnson Douglas, Thevarajan Irani, McGrath Christian, Matlock Amelia, Prestedge Jacqueline, Gooey Megan, Roney Janine, Bobbitt Joanne, Yallop Sarah, Catton Mike, Williamson Deborah A
Microbiology Unit, Alfred Hospital, Melbourne, Victoria, Australia.
Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Lancet Reg Health West Pac. 2022 Sep;26:100533. doi: 10.1016/j.lanwpc.2022.100533. Epub 2022 Jul 8.
Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for regular testing. In this multi-centre evaluation, we aimed to validate RT-PCR using salivary swab testing of SARS-CoV-2 for large-scale surveillance testing and assess implementation amongst staff working in the hotel quarantine system in Victoria, Australia.
A multi-centre laboratory evaluation study was conducted to systematically validate the and clinical performance of salivary swab RT-PCR for implementation of SARS-CoV-2 surveillance testing. Analytical sensitivity for multiple RT-PCR platforms was assessed using a dilution series of known SARS-CoV-2 viral loads, and assay specificity was examined using a panel of viral pathogens other than SARS-CoV-2. In addition, we tested capacity for large-scale saliva testing using a four-sample pooling approach, where positive pools were subsequently decoupled and retested. Regular, frequent self-collected saliva swab RT-PCR testing was implemented for staff across fourteen quarantine hotels. Samples were tested at three diagnostic laboratories validated in this study, and results were provided back to staff in real-time.
The agreement of self-collected saliva swabs for RT-PCR was 84.5% (95% CI 68.6 to 93.8) compared to RT-PCR using nasal/oropharyngeal swab samples collected by a healthcare practitioner, when saliva samples were collected within seven days of symptom onset. Between 7th December 2020 and 17th December 2021, almost 500,000 RT-PCR tests were performed on saliva swabs self-collected by 102 staff working in quarantine hotels in Melbourne. Of these, 20 positive saliva swabs were produced by 13 staff (0.004%). The majority of staff that tested positive occurred during periods of community transmission of the SARS-CoV-2 Delta variant.
Salivary RT-PCR had an acceptable level of agreement compared to standard nasal/oropharyngeal swab RT-PCR within early symptom onset. The scalability, tolerability and ease of self-collection highlights utility for frequent or repeated testing in high-risk settings, such as quarantine or healthcare environments where regular monitoring of staff is critical for public health, and protection of vulnerable populations.
This work was funded by the Victorian Department of Health.
定期重复监测检测是一种在高风险工作场所识别无症状新冠病毒感染者以防止病毒在社区进一步传播的策略。与鼻拭子/咽拭子采样相比,唾液采样侵入性较小,因此适合进行定期检测。在这项多中心评估中,我们旨在验证使用唾液拭子检测新冠病毒的逆转录聚合酶链反应(RT-PCR)用于大规模监测检测的效果,并评估其在澳大利亚维多利亚州酒店隔离系统工作人员中的实施情况。
开展了一项多中心实验室评估研究,以系统验证唾液拭子RT-PCR用于新冠病毒监测检测的分析性能和临床性能。使用一系列已知新冠病毒载量的稀释样本评估多个RT-PCR平台的分析灵敏度,并使用一组除新冠病毒外的病毒病原体检测检测方法的特异性。此外,我们采用四样本混合方法测试了大规模唾液检测的能力,阳性混合样本随后进行解耦并重新检测。对14家隔离酒店的工作人员实施定期、频繁的自我采集唾液拭子RT-PCR检测。样本在本研究中验证的三个诊断实验室进行检测,并将结果实时反馈给工作人员。
当在症状出现后7天内采集唾液样本时,与医护人员采集的鼻拭子/咽拭子样本进行RT-PCR检测相比,自我采集唾液拭子进行RT-PCR检测的一致性为84.5%(95%置信区间为68.6%至93.8%)。在2020年12月7日至2021年12月17日期间,对墨尔本隔离酒店102名工作人员自我采集的唾液拭子进行了近50万次RT-PCR检测。其中,13名工作人员(0.004%)的唾液拭子检测呈阳性。大多数检测呈阳性的工作人员出现在新冠病毒德尔塔变异株社区传播期间。
在症状出现早期,唾液RT-PCR与标准鼻拭子/咽拭子RT-PCR相比具有可接受的一致性水平。其可扩展性、耐受性和自我采集的便利性凸显了其在高风险环境中进行频繁或重复检测的实用性,例如在隔离或医疗环境中,对工作人员进行定期监测对公共卫生以及保护弱势群体至关重要。
这项工作由维多利亚州卫生部资助。